Repligen Analyst Price Targets

Repligen Corp

RGENNASDAQ

$167.60

-2.01-1.19%

À la clôture: Sep 4, 5:00 PM EST

$167.60

N/A

Après les heures: 4:00 PM EST

Wall Street analyst price targets and consensus rating for Repligen (RGEN).

Price Target Range — 13 Quarters

Analyst Consensus — 18 Analysts

15Buy

3Hold

Consensus RatingBuy# Analysts18Avg. Consensus PT$173Upside to Avg. PT+3.4%

Rating Trend — Last 9 Months

Date	Firm	Analyst	Action	Rating Change	Price Target
Jul 30, 2026	Wells Fargo	Evan Stampler	PT Raise	Overweight	$180→$185
Jul 29, 2026	JP Morgan	Casey Woodring	PT Raise	Overweight	$165→$175
Jul 7, 2026	Benchmark	Robert Wasserman	Upgrade	Hold→Buy	$185
Jul 6, 2026	Evercore ISI Group	Daniel Markowitz	PT Raise	Outperform	$150→$160
Jun 3, 2026	HSBC	Sidharth Sahoo	PT Cut	Buy	$170→$150
Jun 2, 2026	Wolfe Research	Mike Polark	Assumes	Outperform	$145
May 15, 2026	RBC Capital	Dan Leonard	Reinstates	Outperform	$160
May 6, 2026	JP Morgan	Casey Woodring	PT Cut	Overweight	$180→$165
May 6, 2026	Barclays	Luke Sergott	PT Raise	Overweight	$145→$160
Apr 20, 2026	Canaccord Genuity	Kyle Mikson	PT Cut	Hold	$165→$145
Apr 17, 2026	Roth Capital	Natalya Davies	Initiate	Buy	$160
Apr 14, 2026	Barclays	Luke Sergott	PT Cut	Overweight	$175→$145
Apr 6, 2026	Evercore ISI Group	Daniel Markowitz	PT Cut	Outperform	$170→$140
Mar 23, 2026	HC Wainwright & Co.	Raghuram Selvaraju	PT Raise	Buy	$180→$208
Feb 25, 2026	UBS	Dan Leonard	PT Cut	Buy	$200→$195
Feb 25, 2026	Barclays	Luke Sergott	PT Cut	Overweight	$200→$175
Feb 25, 2026	Wells Fargo	Brandon Couillard	PT Cut	Overweight	$190→$180
Feb 25, 2026	Evercore ISI Group	Daniel Markowitz	PT Cut	Outperform	$180→$170
Jan 16, 2026	UBS	Dan Leonard	PT Raise	Buy	$190→$200
Dec 15, 2025	Barclays	Luke Sergott	PT Raise	Overweight	$175→$200